Biotechnology

Baird Venture Partners, a unit of Milwaukee-based Robert W. Baird & Co., has joined with the State of Wisconsin Investment Board to lead a $6.2 million investment into Zurex Pharma, a Madison biotechnology firm developing products aimed at preventing infections, in the biotech's first major funding round.  

OTTAWA, Ontario--(BUSINESS WIRE)--BIOTECanada announced earlier today Therapure Biopharma Inc. (Therapure) has been named recipient of a Gold Leaf Award recognizing an outstanding early stage health company.  

Tags: biotech diagnosis stocks, biotech news, biotech penny stocks, biotech stock market, biotech stocks, biotech stocks awaiting fda approval, biotech stocks list, biotech stocks to buy, biotech stocks to watch, investing biotech companies, investing in biotech stocks, investing in biotechnology companies, trade biotech stocks  

The biotechnology buyout binge continued this week, driving profits for those investing in biotech stocks. The sector's latest M&A news picks up a story that began in April, when Human Genome Sciences (Nasdaq: HGSI), the U.S. pioneer of gene-based drug discovery, rebuffed a $2.6 billion bid from Britain's GlaxoSmithKline (NYSE ADR: GSK). Human Genome argued the unsolicited bid did not reflect the company's inherent value. GSK adamantly...  

Why is the biotechnology sector still strong? Despite all the gloom and doom in the markets over the past 60 days the biotechnology sector has barely flinched and is currently at YTD highs. Bellwether ETFs IBB (126) and XBI ($82.85) are up over 20% YTD ...  

For example, the Nasdaq Biotechnology Index rose 457% from the end of August 1998 to the end of February 2000, writes Don Miller at Money Morning. "The good news for investors is that after slumping during the recession, biotech stocks are making a comeback.  

So far, 2012 has been the best year for the Biotechnology and Drugs industry. So many stocks have surged in the last four months based on clinical trial results, U.S. Food and Drug Administration (FDA) approval, FDA Advisory Committee's recommendation ...